Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study

Christiane Wiefels; Willy Weng; Rob Beanlands; Rob deKemp; Pablo B. Nery; Kevin Boczar; Claudio Tinoco Mesquita; David Birnie

American Heart Journal Plus (Dec 2022)

Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study

Christiane Wiefels,
Willy Weng,
Rob Beanlands,
Rob deKemp,
Pablo B. Nery,
Kevin Boczar,
Claudio Tinoco Mesquita,
David Birnie

Affiliations

Christiane Wiefels: University of Ottawa, Department of Medicine, Division of Nuclear Medicine, Ottawa, ON, Canada; Universidade Federal Fluminense, Pós-Graduação em Ciências Cardiovasculares, Niterói, Rio de Janeiro, Brazil
Willy Weng: University of Ottawa Heart Institute, Arrhythmia Service, Division of Cardiology, Department of Medicine, Ottawa, ON, Canada
Rob Beanlands: University of Ottawa Heart Institute, The National Cardiac PET Center, Department of Medicine, Division of Cardiology, Ottawa, ON, Canada
Rob deKemp: University of Ottawa Heart Institute, The National Cardiac PET Center, Department of Medicine, Division of Cardiology, Ottawa, ON, Canada
Pablo B. Nery: University of Ottawa Heart Institute, Arrhythmia Service, Division of Cardiology, Department of Medicine, Ottawa, ON, Canada
Kevin Boczar: University of Ottawa Heart Institute, The National Cardiac PET Center, Department of Medicine, Division of Cardiology, Ottawa, ON, Canada
Claudio Tinoco Mesquita: Universidade Federal Fluminense, Pós-Graduação em Ciências Cardiovasculares, Niterói, Rio de Janeiro, Brazil
David Birnie: University of Ottawa Heart Institute, Arrhythmia Service, Division of Cardiology, Department of Medicine, Ottawa, ON, Canada; Corresponding author at: Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Room H1285, Ottawa, ON K1Y 4W7, Canada.

Journal volume & issue: Vol. 24
p. 100224

Abstract

Read online

Introduction: Data indicates there are 4 main pulmonary sarcoidosis duration/treatment phenotypes: asymptomatic, acute (disease duration 25 % response. Secondly, a trial of therapy discontinuation was able to classify 7/19 patients as acute treatment phenotype and 12/19 as chronic.

Published in American Heart Journal Plus

ISSN: 2666-6022 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.journals.elsevier.com/american-heart-journal-plus-cardiology-research-and-practice

About the journal

Abstract

Keywords